Xiaolin Xu, Founding Partner and Chairman of the Board of Huagai Capital, Founding Chairman of "China Healthcare Investment Forum of 50" (H50), Bachelor of International Economics & EMBA from Peking University

He has led Huagai Capital to establish industrial funds in Healthcare, TMT and digital innovation, with an AUM of nearly 20 billion RMB. He was the General Manager of CCB International Industrial Fund, Director of CCB International Asset Management, and the founder of the private investment sector of CCB International. He has managed funds under CCB International with a total AUM of 15 billion RMB, and has successfully established the first RMB medical industrial fund in China.

With over 15 years of experience in medical and health investment, he has led the investment of multiple industry-leading companies including Kelun Pharmaceutical, Liaoning Chengda Biotechnology, BioKangtai, General Healthy, Shukun Tecknology, Joinn Biologics and MicuRx Pharmaceuticals, and has helped over 50 companies in going public.